Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 700 participants.

Also called NCT01400373

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 700 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01400373
Other papers using this trial's data
  • Effect of Trans-Nasal Evaporative Intra-arrest Cooling on Functional Neurologic Outcome in Out-of-Hospital Cardiac Arrest: The PRINCESS Randomized Clinical Trial JAMA, 2019-05-07 DOI, PubMed 31063573, PMC6506882 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01400373. Randomized; single masking; primary purpose treatment. Start 2010-07-06 (actual); primary completion 2018-01-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prehospital Resuscitation Intra Nasal Cooling Effectiveness Survival Study
Acronym
PRINCESS
Condition
Out-of-hospital Cardiac Arrest
Intervention (Device)
Prehospital intra-nasal cooling with RhinoChill
Lead sponsor
Karolinska Institutet (class: other)
Collaborator
Erasme University Hospital (class: other)
Collaborator
University Hospital Hradec Kralove (class: other)
Collaborator
CHU de Charleroi (class: other)
Collaborator
University Hospital, Lille (class: other)
Collaborator
Karolinska University Hospital (class: other)
Collaborator
BeneChill, Inc (class: industry)

Record details

Record id
cardio:ct-nct01400373
Content hash
dd756dfc1abd2949819d826543774338fa4636b54301ca2e1bc427fea6d4ebe9